Derm-Biome Pharmaceuticals’ Multi-Target Topical Drug Produces Positive Results in Preclinical Study in Acne
09 janv. 2023 10h00 HE
|
Derm-Biome Pharmaceuticals, Inc
VANCOUVER, British Columbia, Jan. 09, 2023 (GLOBE NEWSWIRE) -- Derm-Biome Pharmaceuticals, Inc, a Vancouver based biopharmaceutical company focused on skin health, is pleased to announce that in a...
Insights on the Canine Atopic Dermatitis Global Market to 2027 - Increasing Occurrence of CAD in Domesticated Dogs Drives Growth
06 janv. 2023 06h58 HE
|
Research and Markets
Dublin, Jan. 06, 2023 (GLOBE NEWSWIRE) -- The "Canine Atopic Dermatitis Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ...
$1.1 Billion Worldwide Phototherapy Equipment Industry to 2027: Featuring Atom Medical, AVI Healthcare, General Electric and Herbert Waldmann Among Others
26 déc. 2022 05h43 HE
|
Research and Markets
Dublin, Dec. 26, 2022 (GLOBE NEWSWIRE) -- The "Phototherapy Equipment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ...
STRATA Skin Sciences to Report Third Quarter 2022 Financial Results on November 9, 2022
26 oct. 2022 16h05 HE
|
STRATA Skin Sciences, Inc.
HORSHAM, Pa., Oct. 26, 2022 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for...
Eczema Clinical Trial Pipeline Insights | DelveInsight
11 août 2022 13h00 HE
|
DelveInsight Business Research LLP
New York, USA, Aug. 11, 2022 (GLOBE NEWSWIRE) -- Eczema Clinical Trial Pipeline Insights | DelveInsight The prevalence of eczema is rising since the past few years, which prompts the growing demand...
Arcutis Announces Data Comparing the Vehicle in Investigational Roflumilast Cream Against a Commercial Ceramide-Containing Moisturizing Cream
13 déc. 2021 08h00 HE
|
Arcutis Biotherapeutics, Inc.
Data presented at Revolutionizing Atopic Dermatitis (RAD) ConferenceVehicle tested was comparable to the moisturizing cream based on primary endpoint of change in transepidermal water loss (TEWL) from...
Derm-Biome Pharmaceuticals, Inc. reports Positive Results from a Preclinical Study in Atopic Dermatitis: its new generation of compounds are significantly more effective than FDA-approved topical AD drug crisaborole
16 sept. 2021 10h00 HE
|
Derm-Biome Pharmaceuticals, Inc
VANCOUVER, British Columbia, Sept. 16, 2021 (GLOBE NEWSWIRE) -- Derm-Biome Pharmaceuticals, Inc, a Vancouver based biopharmaceutical company focused on skin health and healthy ageing, is pleased to...
GetSkinHelp.com launches service that reduces wait times to see a dermatologist from several months to mere hours
11 mars 2021 10h30 HE
|
Skinopathy
TORONTO, March 11, 2021 (GLOBE NEWSWIRE) -- Skinopathy Inc., a Canadian medical technology company, is expanding and introducing a new service through its flagship platform, GetSkinHelp.com, that...
Derm-Biome Pharmaceuticals, Inc. Reports Positive Results from a Preclinical Study In Psoriasis
06 oct. 2020 09h30 HE
|
Derm-Biome Pharmaceuticals, Inc
VANCOUVER, British Columbia, Oct. 06, 2020 (GLOBE NEWSWIRE) -- Derm-Biome Pharmaceuticals, Inc, a private Vancouver based biopharmaceutical company focused on skin health and healthy ageing, is...
New Eczema Report Depicts Enormous Burdens and Huge Unmet Medical Needs
18 mars 2020 11h00 HE
|
Asthma and Allergy Foundation of America
Washington, D.C., March 18, 2020 (GLOBE NEWSWIRE) -- Today, five organizations jointly release the “More Than Skin Deep” Voice of the Patient report summarizing outcomes from a September 2019...